Basic principles in preclinical cancer chemotherapy-Reference-Cited by-同舟云学术

Basic principles in preclinical cancer chemotherapy

Published:1990-09 Issue:5 Volume:116 Page:411-424
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Brock Norbert,Pohl Jörg,Schneider Berthold

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/BF01612986.pdf

Reference68 articles.

1. Alarcon RA (1976) Studies on the in vivo formation of acrolein: 3-hydroxypropylmercapturic acid as an index of cyclophosphamide (NSC-26271) activation. Cancer Treat Rep 60:327–335

2. Arnold H, Bourseaux F, Brock N (1958) Neuartige Krebs-Chemotherapeutika aus der Gruppe der zyklischen N-Lost-Phosphamidester. Naturwissenschaften 45:64–66

3. Boyd MR, Shoemaker RH, McLemore TL, Johnston MR, Alley MC, Scudiero DA, Monks A, Fine DL, Mayo JG, Chabner BA (1989) New drug development. In: Roth JA, Ruckdeschel JC, Weisenburger TH (eds) Thoracic oncology. Saunders, Philadelphia, pp 711–721

4. Brade WP, Herdrich K, Varini M (1985) Ifosfamide. Pharmacology, safety and therapeutic potential. Cancer Treat Rev 12:1–47

5. Brock N (1958) Zur pharmakologischen Charakterisierung zyklischer N-Lost-Phosphamidester als Krebs-Chemotherapeutica. Arzneimittelforschung (Drug Res) 8:1–9

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Zytostatika;Pharmakologie und Toxikologie;2002

2. Zytostatika und Immunsuppressiva;Pharmakologie und Toxikologie;1999

3. Zytostatika und Immunsuppressiva;Pharmakologie und Toxikologie;1997

4. The history of the oxazaphosphorine cytostatics;Cancer;1996-08-01